IASiS: Towards heterogeneous big data analysis for personalized medicine

Research output: Chapter in book/report/conference proceedingConference contributionResearchpeer review

Authors

  • Anastasia Krithara
  • Fotis Aisopos
  • Vassiliki Rentoumi
  • Anastasios Nentidis
  • Konstantinos Bougatiotis
  • Maria Esther Vidal
  • Ernestina Menasalvas
  • Alejandro Rodriguez-Gonzalez
  • Eleftherios Samaras
  • Peter Garrard
  • Maria Torrente
  • Mariano Provencio Pulla
  • Nikos Dimakopoulos
  • Rui Mauricio
  • Jordi Rambla De Argila
  • Gian Gaetano Tartaglia
  • George Paliouras

Research Organisations

External Research Organisations

  • National Centre For Scientific Research Demokritos (NCSR Demokritos)
  • Centre for Biomedical Technology (CTB)
  • St. George's University of London
  • Universidad Autónoma de Madrid
  • Athens Technology Center
  • Alzheimer's Research UK
  • CRG - Centre for Genomic Regulation
View graph of relations

Details

Original languageEnglish
Title of host publicationProceedings
Subtitle of host publication2019 IEEE 32nd International Symposium on Computer-Based Medical Systems, CBMS 2019
PublisherInstitute of Electrical and Electronics Engineers Inc.
Pages106-111
Number of pages6
ISBN (electronic)9781728122861
ISBN (print)978-1-7281-2287-8
Publication statusPublished - 2019
Event32nd IEEE International Symposium on Computer-Based Medical Systems, CBMS 2019 - Cordoba, Spain
Duration: 5 Jun 20197 Jun 2019

Publication series

NameProceedings - IEEE Symposium on Computer-Based Medical Systems
Volume2019-June
ISSN (Print)1063-7125

Abstract

The vision of IASIS project is to turn the wave of big biomedical data heading our way into actionable knowledge for decision makers. This is achieved by integrating data from disparate sources, including genomics, electronic health records and bibliography, and applying advanced analytics methods to discover useful patterns. The goal is to turn large amounts of available data into actionable information to authorities for planning public health activities and policies. The integration and analysis of these heterogeneous sources of information will enable the best decisions to be made, allowing for diagnosis and treatment to be personalised to each individual. The project offers a common representation schema for the heterogeneous data sources. The iASiS infrastructure is able to convert clinical notes into usable data, combine them with genomic data, related bibliography, image data and more, and create a global knowledge base. This facilitates the use of intelligent methods in order to discover useful patterns across different resources. Using semantic integration of data gives the opportunity to generate information that is rich, auditable and reliable. This information can be used to provide better care, reduce errors and create more confidence in sharing data, thus providing more insights and opportunities. Data resources for two different disease categories are explored within the iASiS use cases, dementia and lung cancer.

Keywords

    Big data analysis, Dementia, Electronic health records, Genomics, Lung cancer, Personalized medicine

ASJC Scopus subject areas

Sustainable Development Goals

Cite this

IASiS: Towards heterogeneous big data analysis for personalized medicine. / Krithara, Anastasia; Aisopos, Fotis; Rentoumi, Vassiliki et al.
Proceedings: 2019 IEEE 32nd International Symposium on Computer-Based Medical Systems, CBMS 2019. Institute of Electrical and Electronics Engineers Inc., 2019. p. 106-111 8787467 (Proceedings - IEEE Symposium on Computer-Based Medical Systems; Vol. 2019-June).

Research output: Chapter in book/report/conference proceedingConference contributionResearchpeer review

Krithara, A, Aisopos, F, Rentoumi, V, Nentidis, A, Bougatiotis, K, Vidal, ME, Menasalvas, E, Rodriguez-Gonzalez, A, Samaras, E, Garrard, P, Torrente, M, Provencio Pulla, M, Dimakopoulos, N, Mauricio, R, De Argila, JR, Tartaglia, GG & Paliouras, G 2019, IASiS: Towards heterogeneous big data analysis for personalized medicine. in Proceedings: 2019 IEEE 32nd International Symposium on Computer-Based Medical Systems, CBMS 2019., 8787467, Proceedings - IEEE Symposium on Computer-Based Medical Systems, vol. 2019-June, Institute of Electrical and Electronics Engineers Inc., pp. 106-111, 32nd IEEE International Symposium on Computer-Based Medical Systems, CBMS 2019, Cordoba, Spain, 5 Jun 2019. https://doi.org/10.1109/CBMS.2019.00032
Krithara, A., Aisopos, F., Rentoumi, V., Nentidis, A., Bougatiotis, K., Vidal, M. E., Menasalvas, E., Rodriguez-Gonzalez, A., Samaras, E., Garrard, P., Torrente, M., Provencio Pulla, M., Dimakopoulos, N., Mauricio, R., De Argila, J. R., Tartaglia, G. G., & Paliouras, G. (2019). IASiS: Towards heterogeneous big data analysis for personalized medicine. In Proceedings: 2019 IEEE 32nd International Symposium on Computer-Based Medical Systems, CBMS 2019 (pp. 106-111). Article 8787467 (Proceedings - IEEE Symposium on Computer-Based Medical Systems; Vol. 2019-June). Institute of Electrical and Electronics Engineers Inc.. https://doi.org/10.1109/CBMS.2019.00032
Krithara A, Aisopos F, Rentoumi V, Nentidis A, Bougatiotis K, Vidal ME et al. IASiS: Towards heterogeneous big data analysis for personalized medicine. In Proceedings: 2019 IEEE 32nd International Symposium on Computer-Based Medical Systems, CBMS 2019. Institute of Electrical and Electronics Engineers Inc. 2019. p. 106-111. 8787467. (Proceedings - IEEE Symposium on Computer-Based Medical Systems). doi: 10.1109/CBMS.2019.00032
Krithara, Anastasia ; Aisopos, Fotis ; Rentoumi, Vassiliki et al. / IASiS : Towards heterogeneous big data analysis for personalized medicine. Proceedings: 2019 IEEE 32nd International Symposium on Computer-Based Medical Systems, CBMS 2019. Institute of Electrical and Electronics Engineers Inc., 2019. pp. 106-111 (Proceedings - IEEE Symposium on Computer-Based Medical Systems).
Download
@inproceedings{5bbb1749682d4376a37667502c228af9,
title = "IASiS: Towards heterogeneous big data analysis for personalized medicine",
abstract = "The vision of IASIS project is to turn the wave of big biomedical data heading our way into actionable knowledge for decision makers. This is achieved by integrating data from disparate sources, including genomics, electronic health records and bibliography, and applying advanced analytics methods to discover useful patterns. The goal is to turn large amounts of available data into actionable information to authorities for planning public health activities and policies. The integration and analysis of these heterogeneous sources of information will enable the best decisions to be made, allowing for diagnosis and treatment to be personalised to each individual. The project offers a common representation schema for the heterogeneous data sources. The iASiS infrastructure is able to convert clinical notes into usable data, combine them with genomic data, related bibliography, image data and more, and create a global knowledge base. This facilitates the use of intelligent methods in order to discover useful patterns across different resources. Using semantic integration of data gives the opportunity to generate information that is rich, auditable and reliable. This information can be used to provide better care, reduce errors and create more confidence in sharing data, thus providing more insights and opportunities. Data resources for two different disease categories are explored within the iASiS use cases, dementia and lung cancer.",
keywords = "Big data analysis, Dementia, Electronic health records, Genomics, Lung cancer, Personalized medicine",
author = "Anastasia Krithara and Fotis Aisopos and Vassiliki Rentoumi and Anastasios Nentidis and Konstantinos Bougatiotis and Vidal, {Maria Esther} and Ernestina Menasalvas and Alejandro Rodriguez-Gonzalez and Eleftherios Samaras and Peter Garrard and Maria Torrente and {Provencio Pulla}, Mariano and Nikos Dimakopoulos and Rui Mauricio and {De Argila}, {Jordi Rambla} and Tartaglia, {Gian Gaetano} and George Paliouras",
note = "Funding information: II. RELATED WORK Currently there are several efforts made by various international projects, which try to process and integrate various types of data towards the achievement of precision medicine. In specific Dementias Platform UK (DPUK)1is a public-private partnership funded by the Medical Research Council. DPUK brings data from multiple cohorts into the DPUK Data Portal. By joining data DPUK provides an integrated and collaborative environment, bringing together scientists from academia and industry to share knowledge and conduct joint research programs with the goal to fight to develop effective treatments for Dementia fast. The large number of individuals DPUK cohorts allows key research questions to be answered more rigorously and more rapidly than would otherwise be possible. In essence, DPUK involves the collection of various dementia related data sources ranging from HER (electronic health records), brain imaging and brain cell data. The DPUK platform encourages the development of new tools and resources to deliver research to accelerate pathways for future medicines. Moreover, TRACERx2(TRAcking Cancer Evolution through therapy (Rx)) is a translational research study aimed at transforming our understanding of cancer evolution and take a practical step towards an era of precision medicine. It employs observational cohort data and aims at analyzing intra-tumor heterogeneity in order to help the development of novel, targeted and immune based therapies. ACKNOWLEDGMENT This paper is supported by European Union's Horizon 2020 research and innovation programme under grant agreement No. 727658, project IASIS (Integration and analysis of heterogeneous big data for precision medicine and suggested treatments for different types of patients). ; 32nd IEEE International Symposium on Computer-Based Medical Systems, CBMS 2019 ; Conference date: 05-06-2019 Through 07-06-2019",
year = "2019",
doi = "10.1109/CBMS.2019.00032",
language = "English",
isbn = "978-1-7281-2287-8",
series = "Proceedings - IEEE Symposium on Computer-Based Medical Systems",
publisher = "Institute of Electrical and Electronics Engineers Inc.",
pages = "106--111",
booktitle = "Proceedings",
address = "United States",

}

Download

TY - GEN

T1 - IASiS

T2 - 32nd IEEE International Symposium on Computer-Based Medical Systems, CBMS 2019

AU - Krithara, Anastasia

AU - Aisopos, Fotis

AU - Rentoumi, Vassiliki

AU - Nentidis, Anastasios

AU - Bougatiotis, Konstantinos

AU - Vidal, Maria Esther

AU - Menasalvas, Ernestina

AU - Rodriguez-Gonzalez, Alejandro

AU - Samaras, Eleftherios

AU - Garrard, Peter

AU - Torrente, Maria

AU - Provencio Pulla, Mariano

AU - Dimakopoulos, Nikos

AU - Mauricio, Rui

AU - De Argila, Jordi Rambla

AU - Tartaglia, Gian Gaetano

AU - Paliouras, George

N1 - Funding information: II. RELATED WORK Currently there are several efforts made by various international projects, which try to process and integrate various types of data towards the achievement of precision medicine. In specific Dementias Platform UK (DPUK)1is a public-private partnership funded by the Medical Research Council. DPUK brings data from multiple cohorts into the DPUK Data Portal. By joining data DPUK provides an integrated and collaborative environment, bringing together scientists from academia and industry to share knowledge and conduct joint research programs with the goal to fight to develop effective treatments for Dementia fast. The large number of individuals DPUK cohorts allows key research questions to be answered more rigorously and more rapidly than would otherwise be possible. In essence, DPUK involves the collection of various dementia related data sources ranging from HER (electronic health records), brain imaging and brain cell data. The DPUK platform encourages the development of new tools and resources to deliver research to accelerate pathways for future medicines. Moreover, TRACERx2(TRAcking Cancer Evolution through therapy (Rx)) is a translational research study aimed at transforming our understanding of cancer evolution and take a practical step towards an era of precision medicine. It employs observational cohort data and aims at analyzing intra-tumor heterogeneity in order to help the development of novel, targeted and immune based therapies. ACKNOWLEDGMENT This paper is supported by European Union's Horizon 2020 research and innovation programme under grant agreement No. 727658, project IASIS (Integration and analysis of heterogeneous big data for precision medicine and suggested treatments for different types of patients).

PY - 2019

Y1 - 2019

N2 - The vision of IASIS project is to turn the wave of big biomedical data heading our way into actionable knowledge for decision makers. This is achieved by integrating data from disparate sources, including genomics, electronic health records and bibliography, and applying advanced analytics methods to discover useful patterns. The goal is to turn large amounts of available data into actionable information to authorities for planning public health activities and policies. The integration and analysis of these heterogeneous sources of information will enable the best decisions to be made, allowing for diagnosis and treatment to be personalised to each individual. The project offers a common representation schema for the heterogeneous data sources. The iASiS infrastructure is able to convert clinical notes into usable data, combine them with genomic data, related bibliography, image data and more, and create a global knowledge base. This facilitates the use of intelligent methods in order to discover useful patterns across different resources. Using semantic integration of data gives the opportunity to generate information that is rich, auditable and reliable. This information can be used to provide better care, reduce errors and create more confidence in sharing data, thus providing more insights and opportunities. Data resources for two different disease categories are explored within the iASiS use cases, dementia and lung cancer.

AB - The vision of IASIS project is to turn the wave of big biomedical data heading our way into actionable knowledge for decision makers. This is achieved by integrating data from disparate sources, including genomics, electronic health records and bibliography, and applying advanced analytics methods to discover useful patterns. The goal is to turn large amounts of available data into actionable information to authorities for planning public health activities and policies. The integration and analysis of these heterogeneous sources of information will enable the best decisions to be made, allowing for diagnosis and treatment to be personalised to each individual. The project offers a common representation schema for the heterogeneous data sources. The iASiS infrastructure is able to convert clinical notes into usable data, combine them with genomic data, related bibliography, image data and more, and create a global knowledge base. This facilitates the use of intelligent methods in order to discover useful patterns across different resources. Using semantic integration of data gives the opportunity to generate information that is rich, auditable and reliable. This information can be used to provide better care, reduce errors and create more confidence in sharing data, thus providing more insights and opportunities. Data resources for two different disease categories are explored within the iASiS use cases, dementia and lung cancer.

KW - Big data analysis

KW - Dementia

KW - Electronic health records

KW - Genomics

KW - Lung cancer

KW - Personalized medicine

UR - http://www.scopus.com/inward/record.url?scp=85071002424&partnerID=8YFLogxK

U2 - 10.1109/CBMS.2019.00032

DO - 10.1109/CBMS.2019.00032

M3 - Conference contribution

AN - SCOPUS:85071002424

SN - 978-1-7281-2287-8

T3 - Proceedings - IEEE Symposium on Computer-Based Medical Systems

SP - 106

EP - 111

BT - Proceedings

PB - Institute of Electrical and Electronics Engineers Inc.

Y2 - 5 June 2019 through 7 June 2019

ER -